Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
See Commentary on Page 759 See Commentary on Page 759
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028 · cited 1×
“It is also well recognized that a large proportion of patients with CG carry 2 allelic risk variants of APOL1, namely G1 and G2, which are common in individuals of West African ancestry and also confer risk for hypertension-attributed end-stage kidney disease.(7) Indeed, the APOL1 high-risk genotype (either G1/G1, G1/…”
BackgroundInnate immunity pathways regulate the nephropathy gene Apolipoprotein L1
Nichols, B., Jog, P., Lee, J. H., Blackler, D., Wilmot, M., D'Agati, V., Markowitz, G., Kopp, J. B., Alper, S. L., Pollak, M. R., et al. (2015) · Kidney International · doi:10.1038/ki.2014.270 · Cited by 355 · cited 2×
“Evidence from animal models and cell culture systems suggests that the highrisk APOL1 genotype may mediate podocyte damage via upregulation of APOL1 through activation of a viral program in the podocyte, leading to dysregulated endosomal trafficking and autophagic flux, resulting in podocyte depletion and glomerular s…”
BackgroundSelf-citationIdiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study
Valeri, A., Barisoni, L., Appel, G. B., Seigle, R., & D'Agati, V. (1996) · Kidney International · doi:10.1038/ki.1996.493 · Cited by 261
Self-citationKopp, J. B., Winkler, C. A., Zhao, X., Radeva, M. K., Gassman, J. J., D’Agati, V. D., Nast, C. C., Wei, C., Reiser, J., Guay-Woodford, L. M., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111242 · Cited by 127 · cited 2×
“In general, patients with 2 high-risk APOL1 alleles have a higher likelihood of eventually reaching end-stage kidney disease, although their response to immunosuppression is not modified by their APOL1 high-risk status.(8) Evidence from animal models and cell culture systems suggests that the highrisk APOL1 genotype m…”
BackgroundSelf-citationEymael, J., Sharma, S., Loeven, M. A., Wetzels, J. F. M., Mooren, F., Florquin, S., Deegens, J. K., Willemsen, B. K., Sharma, V., Kuppevelt, T. H. V., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.09.020 · Cited by 81 · cited 1×
“As podocytes are injured and depleted, the visceral epithelial cells show downregulation and loss of mature podocyte markers with de novo expression of markers associated with proliferation and activated parietal epithelial cells.(3,4) CG not associated with HIV/AIDS may be idiopathic or associated with a variety of c…”
BackgroundMorphologic Variants of Focal Segmental Glomerulosclerosis and Their Significance
Stokes, M. B., & D’Agati, V. D. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.02.010 · Cited by 72 · cited 1×
“Kidney International Reports (2020) 5, 940–945 nonviral infections (such as tuberculosis), autoimmune diseases (such as systemic lupus erythematosus), drug exposures (such as pamidronate and interferon), hemophagocytic syndrome, and acute glomerular ischemia, among others.(5) Many of these exposures are thought to med…”
BackgroundSelf-citation
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Nadim, M. K., Forni, L. G., Mehta, R. L., Connor, M. J., Liu, K. D., Ostermann, M., Rimmelé, T., Zarbock, A., Bell, S., Bihorac, A., et al. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00356-5 · Cited by 690
Pathological sequelae of long-haul COVID
Mehandru, S., & Merad, M. (2022) · Nature Immunology · doi:10.1038/s41590-021-01104-y · Cited by 657
Long-term complications of COVID-19
Desai, A. D., Lavelle, M., Boursiquot, B. C., & Wan, E. Y. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00375.2021 · Cited by 415
Kidney Biopsy Findings in Patients with COVID-19
Kudose, S., Batal, I., Santoriello, D., Xu, K., Barasch, J., Peleg, Y., Canetta, P., Ratner, L. E., Marasa, M., Gharavi, A. G., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020060802 · Cited by 412
Self-citationAKI in Hospitalized Patients with and without COVID-19: A Comparison Study
Fisher, M., Neugarten, J., Bellin, E., Yunes, M., Stahl, L., Johns, T. S., Abramowitz, M. K., Levy, R., Kumar, N., Mokrzycki, M. H., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040509 · Cited by 374
COVID-19–Associated Kidney Injury: A Case Series of Kidney Biopsy Findings
Sharma, P., Uppal, N. N., Wanchoo, R., Shah, H. H., Yang, Y., Parikh, R., Khanin, Y., Madireddy, V., Larsen, C. P., Jhaveri, K. D., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050699 · Cited by 367
Postmortem Kidney Pathology Findings in Patients with COVID-19
Santoriello, D., Khairallah, P., Bomback, A. S., Xu, K., Kudose, S., Batal, I., Barasch, J., Radhakrishnan, J., D’Agati, V., & Markowitz, G. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050744 · Cited by 312
Self-citationAKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype
Wu, H., Larsen, C. P., Hernandez-Arroyo, C. F., Mohamed, M. M. B., Caza, T., Sharshir, M., Chughtai, A., Xie, L., Gimenez, J. M., Sandow, T. A., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050558 · Cited by 282
APOL1 Nephropathy: From Genetics to Clinical Applications
Friedman, D. J., & Pollak, M. R. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15161219 · Cited by 270
Metadata
- Authors
- Peleg, Y., Kudose, S., D’Agati, V., Siddall, E., Ahmad, S., Nickolas, T., Kisselev, S., Gharavi, A., & Canetta, P.
- Venue
- Kidney International Reports
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 5
- Issue
- 6
- Pages
- 940-945
- ISSN
- 2468-0249 (ISSN-L)
- OpenAlex
- W3017853824
- Cited by
- 235
- References
- 6
- FWCI
- 30.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.